Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
The epidemiology and clinical features of portal vein thrombosis: a multicentre study
2010
KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins
2014
Atorvastatin and fluvastatin are associated with dose‐dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES
2016
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics
2013 StandoutNobel
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
2011 Standout
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Endothelin-1 Activation of the Endothelin B Receptor Modulates Pulmonary Endothelial CX3CL1 and Contributes to Pulmonary Angiogenesis in Experimental Hepatopulmonary Syndrome
2014
Sepsis biomarkers: a review
2010 Standout
Hypocalcemia in Patients with Acute Pancreatitis: A Putative Role for Systemic Endotoxin Exposure
2003
Acute kidney injury
2012 Standout
Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone
2005
ROCK induced inflammation of the microcirculation during endotoxemia mediated by nitric oxide synthase
2011
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
Hyponatremia Treatment Guidelines 2007: Expert Panel Recommendations
2007 Standout
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Hepatocellular carcinoma
2018 Standout
Mechanisms of hepatic stellate cell activation
2017 Standout
Burden of liver diseases in the world
2018 Standout
Perioperative Management of Antithrombotic Therapy
2012 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: Possible role of Akt and IRAK-M
2006
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Renal Failure in Cirrhosis
2009
Gastric and Ectopic Varices
2014
Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats
2013
Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis
2015
Human urotensin-II as a novel cardiovascular target: 'heart' of the matter or simply a fishy 'tail'?
2003
Acute-on-chronic liver failure in cirrhosis
2016
Dysbalance in sympathetic neurotransmitter release and action in cirrhotic rats: Impact of exogenous neuropeptide Y
2012
Vasoactive substances in the circulatory dysfunction of cirrhosis
2001
Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial
2009
Prevention of VTE in Nonsurgical Patients
2012 Standout
Role of Differentiation of Liver Sinusoidal Endothelial Cells in Progression and Regression of Hepatic Fibrosis in Rats
2011
Vascular disorders of the liver # †
2008 Standout
Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments
2015
Nociceptin and urotensin-II concentrations in critically ill patients with sepsis
2008
Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity
2006 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Endothelial Dysfunction Caused by Circulating Microparticles from Patients with Metabolic Syndrome
2008
Acute kidney injury
2019 Standout
The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat
2004
Portal hypertensive bleeding in cirrhosis
2016 Standout
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
A Central Role for CD68(+) Macrophages in Hepatopulmonary Syndrome
2010
Executive Summary
2012 Standout
Sepsis and septic shock
2018 Standout
Opposite regulation of endothelial NO synthase by HSP90 and caveolin in liver and lungs of rats with hepatopulmonary syndrome
2007
Activation of eNOS in rat portal hypertensive gastric mucosa is mediated by TNF-α via the PI 3-kinase-Akt signaling pathway
2002
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Modulation of pulmonary endothelial endothelin B receptor expression and signaling: implications for experimental hepatopulmonary syndrome
2007
Hypercoagulability in cirrhosis: causes and consequences
2011
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Laser Printing of Single Cells: Statistical Analysis, Cell Viability, and Stress
2005
AGA technical review on intestinal ischemia
2000 Standout
Pulmonary Angiogenesis in a Rat Model of Hepatopulmonary Syndrome
2008
Hepatorenal Disorders
2015
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Global burden of liver disease: 2023 update
2023 Standout
Implication of inflammation‐related cytokines in the natural history of liver cirrhosis
2004
Pulmonary–Hepatic vascular Disorders (PHD)
2004
Pilot study of pentoxifylline in hepatopulmonary syndrome
2008
Norfloxacin Reduces Aortic NO Synthases and Proinflammatory Cytokine Up-Regulation in Cirrhotic Rats: Role of Akt Signaling
2005
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
The Multifunctional Fish Gill: Dominant Site of Gas Exchange, Osmoregulation, Acid-Base Regulation, and Excretion of Nitrogenous Waste
2004 Standout
The Hyperdynamic Circulation of Chronic Liver Diseases: From the Patient to the Molecule
2006
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Mesenteric Venous Thrombosis
2013
Sorafenib induces autophagic cell death and apoptosis in hepatic stellate cell through the JNK and Akt signaling pathways
2015
Acute Kidney Injury Network Criteria as a Predictor of Hospital Mortality in Cirrhotic Patients With Ascites
2011
Ex vivo effects of high‐density lipoprotein exposure on the lipopolysaccharide‐induced inflammatory response in patients with severe cirrhosis†
2008
The Role of the RhoA/rho-kinase Pathway in Pulmonary Hypertension
2009
Practice Guidelines in Acute Pancreatitis
2006 Standout
Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells
2018 Standout
Renal failure and cirrhosis: A systematic review of mortality and prognosis
2011
Translating an Understanding of the Pathogenesis of Hepatic Fibrosis to Novel Therapies
2013
Thrombophilic dimension of Budd chiari syndrome and portal venous thrombosis – A concise review
2010
Atorvastatin inhibits proliferation and apoptosis, but induces senescence in hepatic myofibroblasts and thereby attenuates hepatic fibrosis in rats
2012
FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis
2016
Portopulmonary hypertension and hepatopulmonary syndrome
2004
Bacterial DNA Translocation Is Associated With Systemic Circulatory Abnormalities and Intrahepatic Endothelial Dysfunction in Patients With Cirrhosis
2010
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
The model for end-stage liver disease (MELD)
2007
Is urotensin‐II the new endothelin?
2002
Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event
2014 StandoutNobel
Cellular senescence: from physiology to pathology
2014 Standout
Prevention of Gram-Negative Translocation Reduces the Severity of Hepatopulmonary Syndrome
2002
Pulmonary Arterial Hypertension in France
2006 Standout
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
Regulation of heme oxygenase-1 by nitric oxide during hepatopulmonary syndrome
2002
Prevalence and impact on survival of hepatopulmonary syndrome and cirrhotic cardiomyopathy in a cohort of cirrhotic patients
2015
Programmed assembly of 3-dimensional microtissues with defined cellular connectivity
2009 StandoutNobel
Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis
2007
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism
2013 Standout
Updates on Hepato-Renal Syndrome
2013
Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung
2015
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Works of Jörg Heller being referenced
Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension
2002
Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells
2010
Acute Portal Vein Thrombosis Unrelated to Cirrhosis: A Prospective Multicenter Follow-Up Study
2009
Altered adrenergic responsiveness of endothelium-denuded hepatic arteries and portal veins in patients with cirrhosis
1999
Vascular dysfunction in human and rat cirrhosis: Role of receptor-desensitizing and calcium-sensitizing proteins
2007
Role of shear stress in aortic eNOS up-regulation in rats with biliary cirrhosis
2002
Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts
2011
Prognostic factors for patients with cirrhosis and kidney dysfunction in the era of MELD: results of a prospective study
2006
Effects of lipopolysaccharide on TNF-α production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis
2000
Role of β3‐adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis†
2009
Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase
2007
Evidence for An Endothelium–Derived Hyperpolarizing Factor in the Superior Mesenteric Artery From Rats With Cirrhosis
2000
Evolution of hypoxemia in patients with severe cirrhosis
2002
Hepatic and HSC-specific sorafenib effects in rats with established secondary biliary cirrhosis
2010
Changes in protein kinase C isoforms in association with vascular hyporeactivity in cirrhotic rat aortas
2000
Role of aortic nitric oxide synthase 3 (eNOS) in the systemic vasodilation of portal hypertension
2000
Defective RhoA/Rho-Kinase Signaling Contributes to Vascular Hypocontractility and Vasodilation in Cirrhotic Rats
2006
Prognostic Impact of Renal Impairment and Sodium Imbalance in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunting for the Prevention of Variceal Rebleeding
2003
Role of Nitric Oxide in Hepatopulmonary Syndrome in Cirrhotic Rats
2001